STAT3 and cancer: Studies in the past few years have provide compelling evidence for the critical role of aberrant STAT3 in malignant transformation and tumorigenesis, thus, it is now generally accepted that STAT3 is one of the critical players in human cancer formation and represents a valid target for novel anti-cancer drug design [10].